These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17159461)

  • 21. Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.
    Anholt GE; van Oppen P; Emmelkamp PM; Cath DC; Smit JH; van Dyck R; van Balkom AJ
    J Anxiety Disord; 2009 Aug; 23(6):830-5. PubMed ID: 19443176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcosine therapy for obsessive compulsive disorder: a prospective, open-label study.
    Wu PL; Tang HS; Lane HY; Tsai CA; Tsai GE
    J Clin Psychopharmacol; 2011 Jun; 31(3):369-74. PubMed ID: 21508860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-related exacerbation of obsessive-compulsive symptoms with quetiapine treatment.
    Chen CH; Chiu CC; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):304-5. PubMed ID: 17826882
    [No Abstract]   [Full Text] [Related]  

  • 24. Course of obsessive-compulsive disorder during early postpartum period: a prospective analysis of 16 cases.
    Uguz F; Gezginc K; Zeytinci IE; Karatayli S; Askin R; Guler O; Sahin FK; Emul HM; Ozbulut O; Gecici O
    Compr Psychiatry; 2007; 48(6):558-61. PubMed ID: 17954142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a long acting GnRH analogue or placebo on plasma LH/FSH, urethral pressure profiles and clinical signs of urinary incontinence due to Sphincter mechanism incompetence in bitches.
    Reichler IM; Jöchle W; Piché CA; Roos M; Arnold S
    Theriogenology; 2006 Sep; 66(5):1227-36. PubMed ID: 16672159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open trial of group metacognitive therapy for obsessive-compulsive disorder.
    Rees CS; van Koesveld KE
    J Behav Ther Exp Psychiatry; 2008 Dec; 39(4):451-8. PubMed ID: 18295186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiandrogenic treatment for obsessive-compulsive disorder.
    Eriksson T
    Am J Psychiatry; 2000 Mar; 157(3):483. PubMed ID: 10698847
    [No Abstract]   [Full Text] [Related]  

  • 28. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder.
    Brown RA; Abrantes AM; Strong DR; Mancebo MC; Menard J; Rasmussen SA; Greenberg BD
    J Nerv Ment Dis; 2007 Jun; 195(6):514-20. PubMed ID: 17568300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
    Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
    Poyurovsky M
    Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
    [No Abstract]   [Full Text] [Related]  

  • 31. Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: follow up.
    Jaurrieta N; Jiménez-Murcia S; Alonso P; Granero R; Segalàs C; Labad J; Menchón JM
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):697-704. PubMed ID: 19068007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic and clinical characteristics associated with treatment status in family members with obsessive-compulsive disorder.
    Cullen B; Samuels JF; Pinto A; Fyer AJ; McCracken JT; Rauch SL; Murphy DL; Greenberg BD; Knowles JA; Piacentini J; Bienvenu OJ; Grados MA; Riddle MA; Rasmussen SA; Pauls DL; Willour VL; Shugart YY; Liang KY; Hoehn-Saric R; Nestadt G
    Depress Anxiety; 2008; 25(3):218-24. PubMed ID: 17345603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
    Greenberg WM; Benedict MM; Doerfer J; Perrin M; Panek L; Cleveland WL; Javitt DC
    J Psychiatr Res; 2009 Mar; 43(6):664-70. PubMed ID: 19046587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alprazolam in the treatment of obsessive symptoms.
    Tollefson G
    J Clin Psychopharmacol; 1985 Feb; 5(1):39-42. PubMed ID: 3973070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessive-compulsive symptoms in schizophrenia: prevalence, correlates and treatment.
    Lysaker PH; Whitney KA
    Expert Rev Neurother; 2009 Jan; 9(1):99-107. PubMed ID: 19102672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive-compulsive and eating disorders: comparison of clinical and personality features.
    Jiménez-Murcia S; Fernández-Aranda F; Raich RM; Alonso P; Krug I; Jaurrieta N; Alvarez-Moya E; Labad J; Menchón JM; Vallejo J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):385-91. PubMed ID: 17610663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of obsessive-compulsive behaviour following cortisone treatment.
    Scheschonka A; Bleich S; Buchwald AB; Ruther E; Wiltfang J
    Pharmacopsychiatry; 2002 Mar; 35(2):72-4. PubMed ID: 11951148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
    Pérez-Medina T; Bajo J; Folgueira G; Haya J; Ortega P
    Gynecol Oncol; 1999 May; 73(2):299-304. PubMed ID: 10329050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder.
    Roth RM; Jobst BC; Thadani VM; Gilbert KL; Roberts DW
    Epilepsy Behav; 2009 Apr; 14(4):677-80. PubMed ID: 19435591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.